ENTITY
Celltrion

Celltrion (068270 KP)

22
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bearishPosco Future M
22 May 2023 07:03

Korea: What Are Foreign Investors Buying & Selling?

Foreign investors have been buying stock in Korea and hold 32% of the KOSPI market cap and 8.5% of the KOSDAQ market cap. There is a big dispersion...

Logo
462 Views
Share
bullishSK Pharmteco
17 May 2023 17:11

SK Pharmteco Pre-IPO Funding & Impact on SK Inc

SK Pharmteco is seeking valuation of about 5 trillion won which is much higher than its book value of 1.65 trillion won. SK Pharmteco (100% owned...

Logo
348 Views
Share
bullishCelltrion Inc
15 May 2023 17:37

Celltrion Inc (068270 KS): Turning Bullish As Biosimilar Revenue Rebounds & US Launches Imminent

Celltrion reported record-high biosimilar quarterly revenue of KRW400B+ in Q1, leading to double-digit revenue and operating profit growth. The...

Logo
263 Views
Share
03 Apr 2023 05:47

Short Interest Movements (Q1 2023): HK, Korea, Taiwan, Australia

The Insight looks at movements in short interest across HK, Korea, Taiwan and Australia stocks over Q1 and highlights large increases/decreases in...

Logo
444 Views
Share
06 Mar 2023 14:53

Long Short Setup Candidate: Posco Holdings & Celltrion with TIGER Top 10 Rebalancing

TIGER Top 10 ETF's upcoming rebalancing, scheduled for June 9, presents a feasible long short trade setup on Posco Holdings and Celltrion.

Logo
415 Views
Share
x